Medical treatment of patients with stable angina pectoris referred for coronary angiography: Failure of treatment or failure to treat

Clinical Cardiology

Volumn 25, Issue 9, 2002, Pages 436-441

  Carasso, Shemy ^a   Markeewicz, Walter ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Angina; Angiography; Catheterization; Coronary disease; Drugs; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FELODIPINE; ISOSORBIDE 5 NITRATE; METOPROLOL; NIFEDIPINE; NITRIC ACID DERIVATIVE; PROPRANOLOL; VERAPAMIL;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY OBSTRUCTION; ELECTIVE SURGERY; FEMALE; HEART CATHETERIZATION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; RISK FACTOR; SYMPTOM; TREATMENT FAILURE;

EID: 0036729510     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960250908     Document Type: Article

References (38)

1. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina
2. Investigation and management of stable angina: Revised guidelines 1998
3. Guidelines on management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology
4. ACC/AHA guidelines for coronary arteriography
5. Rating the appropriateness of coronary angiography-do practicing physicians agree with an expert panel and with each other?
6. Cardiac procedures, outcome, and accountability
7. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study
8. Grading of angina pectoris
9. Factors associated with the use of various medications amongst patients with severe coronary artery disease
10. A European Society of Cardiology survey of coronary heart disease: Principal results
11. Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals
12. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction
13. Cardiologists' practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction
14. Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice
15. Secondary prevention of coronary heart disease in patients after acute myocardial infarction at the Soroka medical center
16. Intensity of antianginal therapy in patients referred for coronary angiography: A comparison of fee-for-service and health maintenance organization therapeutic strategies
17. National patterns and predictors of beta-blocker use in patients with coronary artery disease
18. Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: Results from the GUARANTEE registry
19. Changing patterns in drug therapy for ischemic heart disease
20. Regional variation in medical care
21. The Total Ischaemic Burden European Trial (TIBET): Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina
22. Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements
23. Reversal of coronary atherosclerosis. Clinical promise as the basis for noninvasive management of coronary artery disease
24. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
25. Increasing the impact of cardiological treatments
26. Recommendations for coronary catheterization, revascularization and arrangement of coronary stent (for the Israeli Cardiology Society)
27. Use of coronary angioplasty, bypass surgery, and conservative therapy for treatment of coronary artery disease over the past decade
28. Coronary angioplasty versus medical therapy for angina: The second Randomized Intervention Treatment of Angina (RITA-2) trial
29. Two-to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy
30. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study
31. Eighteen-year follow-up in the veteran affairs cooperative study of coronary artery bypass surgery for stable angina
32. ACC/AHA guidelines for coronary artery bypass graft surgery
33. Management of osteoporosis: A survey of Israeli physicians' knowledge and attitudes
34. Knowledge and practice of primary care physicians relating to streptococcal pharyngitis (Hebrew)
35. Changing physicians' practice
36. Loose connections between peer-reviewed clinical journals and clinical practice
37. Effect of local medical opinion leaders on quality of care for acute myocardial infarction
38. Improving the quality of care for Medicare patients with acute myocardial infarction